Technical Analysis for MYX - Mayne Pharma Group Ltd
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jack-in-the-Box Bearish | Bearish Swing Setup | -1.12% | |
| Inside Day | Range Contraction | -1.12% | |
| Expansion Breakdown | Bearish Swing Setup | 0.45% | |
| Lower Bollinger Band Touch | Weakness | 0.45% | |
| Fell Below 20 DMA | Bearish | -4.53% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -5.94% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -5.94% | |
| Crossed Above 20 DMA | Bullish | -5.94% | |
| Spinning Top | Other | -5.94% | |
| 20 DMA Resistance | Bearish | -4.53% |
| Alert | Time |
|---|---|
| Possible NR7 | about 3 hours ago |
| Lower Bollinger Band Support | about 6 hours ago |
| Down 2% | about 6 hours ago |
| Fell Below Lower Bollinger Band | about 6 hours ago |
| Jack-in-the-Box Bearish Entry | about 6 hours ago |
Get a Trading Sidekick!
Mayne Pharma Group Ltd Description
Mayne Pharma Group Limited is a specialty pharmaceutical company, which focuses on applying its drug delivery capability to commercialize branded and generic pharmaceuticals. The Company also provides contract development and manufacturing services. It operates in four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Manufacturing Pharmaceutical Pharmaceuticals Pharmaceutical Industry Pharmaceuticals Policy Pharmaceutical Industry In China Pharmaceutical Products Drug Delivery Science And Technology In The People's Republic Of China Contract Manufacturing Contract Manufacturing Services Contract Services Pharmaceutical Companies Pharmaceutical Development Generic Drug Generic Pharmaceutical Product Generic Pharmaceutical Products Manufacturing Services
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.46 |
| 52 Week Low | 2.75 |
| Average Volume | 274,977 |
| 200-Day Moving Average | 5.364 |
| 50-Day Moving Average | 5.593 |
| 20-Day Moving Average | 4.624 |
| 10-Day Moving Average | 4.579 |
| Average True Range | 0.198 |
| RSI (14) | 35.48 |
| ADX | 41.59 |
| +DI | 10.759 |
| -DI | 27.983 |
| Chandelier Exit (Long, 3 ATRs) | 4.496 |
| Chandelier Exit (Short, 3 ATRs) | 4.974 |
| Upper Bollinger Bands | 4.865 |
| Lower Bollinger Band | 4.383 |
| Percent B (%b) | 0.2 |
| BandWidth | 10.424 |
| MACD Line | -0.262 |
| MACD Signal Line | -0.318 |
| MACD Histogram | 0.056 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.660 | ||||
| Resistance 3 (R3) | 4.660 | 4.600 | 4.630 | ||
| Resistance 2 (R2) | 4.600 | 4.554 | 4.600 | 4.620 | |
| Resistance 1 (R1) | 4.540 | 4.526 | 4.570 | 4.540 | 4.610 |
| Pivot Point | 4.480 | 4.480 | 4.495 | 4.480 | 4.480 |
| Support 1 (S1) | 4.420 | 4.434 | 4.450 | 4.420 | 4.350 |
| Support 2 (S2) | 4.360 | 4.406 | 4.360 | 4.340 | |
| Support 3 (S3) | 4.300 | 4.360 | 4.330 | ||
| Support 4 (S4) | 4.300 |
